5. LISTING OF DEGRADATION PRODUCTS IN SPECIFICATIONS

The specification for a new drug product should include a list of degradation products expected to occur during manufacture of the commercial product and under recommended storage conditions .The quantitation/detection limit of the analytical procedures should be commensurate with the level at which the degradation products should be controlled .